pyridinolcarbamate has been researched along with Erysipelas in 1 studies
Pyridinolcarbamate: A drug that has been given by mouth in the treatment of atherosclerosis and other vascular disorders, hyperlipidemias, and thrombo-embolic disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1408)
Erysipelas: An acute infection of the skin caused by species of STREPTOCOCCUS. This disease most frequently affects infants, young children, and the elderly. Characteristics include pink-to-red lesions that spread rapidly and are warm to the touch. The commonest site of involvement is the face.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cherkasov, VL | 1 |
| Bol'shakova, TD | 1 |
| Kuznetsov, VA | 1 |
| Obrazberdyev, S | 1 |
| Mikerin, SM | 1 |
1 other study available for pyridinolcarbamate and Erysipelas
| Article | Year |
|---|---|
[The treatment of patients with the hemorrhagic form of erysipelas by using amben and parmidine].
Topics: 4-Aminobenzoic Acid; Adolescent; Adult; Aged; Antifibrinolytic Agents; Drug Evaluation; Erysipelas; | 1990 |